SCHEMBL14097686

SCHEMBL14097686

CCNC(=O)Nc1nc2cc(-c3cnc(N)nc3)cc(C)c2o1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 4/20 0.40
▸ PIK3CA P42336 6/20 0.39
▸ MAPK1 P28482 6/20 0.39
▸ MAPK8 P45983 3/20 0.39
▸ MAPK9 P45984 3/20 0.39
▸ MAPK10 P53779 3/20 0.39
▸ ALOX5AP P20292 1/20 0.38
▸ FGFR1 P11362 3/20 0.38
▸ AURKB Q96GD4 2/20 0.38
▸ SRC P12931 2/20 0.38
▸ PIM1 P11309 1/20 0.38
▸ YES1 P07947 1/20 0.37
▸ HIPK1 Q86Z02 1/20 0.37
▸ EGFR P00533 1/20 0.36
▸ FGFR2 P21802 1/20 0.36
▸ FGFR4 P22455 1/20 0.36
▸ FGFR3 P22607 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14097692 0.88 ABL1 (0.40) ABL1PIK3CAMAPK1MAPK8MAPK9
SCHEMBL14097698 0.87 ABL1 (0.39) ABL1PIK3CAMAPK1MAPK8MAPK9
SCHEMBL14395390 0.87 ABL1 (0.41) ABL1
SCHEMBL14097687 0.84 MAPK8 (0.41) ABL1MAPK1MAPK8MAPK9MAPK10
SCHEMBL14097697 0.81 PIK3CA (0.36) ABL1PIK3CAMAPK1AURKBPIM1
SCHEMBL14097693 0.79 ABL1 (0.43) ABL1
SCHEMBL14097684 0.75 ABL1 (0.41) ABL1
SCHEMBL14097699 0.73 TP53 (0.31) —
SCHEMBL2739814 0.72 PIK3CA (0.47) ABL1PIK3CA
SCHEMBL14097711 0.72 ABL1 (0.49) ABL1PIK3CAMAPK1MAPK8MAPK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7414046-B2 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-08-19 — — US disclosed
US-7414046-B2 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-08-19 — — US disclosed
US-RE40245-E1 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-04-15 — — US disclosed
US-RE40245-E1 Gyrase inhibitors and uses thereof VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-04-15 — — US disclosed
EP-1341769-B1 BACTERIAL GYRASE INHIBITORS AND USES THEREOF VERTEX PHARMA (US) 2007-10-17 — — EP disclosed
Send feedback